SCHEMBL8444112

SCHEMBL8444112

[CH2][C@H]1CCCN1C(=O)Cc1c[nH]cn1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ PREP P48147 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8800654 0.76 CNR2 (0.33) —
SCHEMBL844906 0.72 HCRTR1 (0.44) —
SCHEMBL9555245 0.70 ACE (0.48) —
SCHEMBL7449469 0.70 ALDH1A1 (0.38) SMN1; SMN2
SCHEMBL3462006 0.70 MC4R (0.53) SMN1; SMN2HPGD
SCHEMBL27918437 0.70 MC4R (0.53) SMN1; SMN2HPGD
SCHEMBL15129887 0.69 PREP (0.65) PREP
SCHEMBL21696926 0.69 CCNK (0.34) —
SCHEMBL5165856 0.69 MAPT (0.44) —
SCHEMBL6930338 0.68 ATM (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0952842-A2 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 1999-11-03 — — EP claimed
WO-1997038664-A2 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1997-10-23 — — WO claimed
EP-0952842-A2 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 1999-11-03 — — EP disclosed
WO-1997038664-A2 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1997-10-23 — — WO disclosed
EP-0783518-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO. INC. (US) 1997-07-16 — — EP disclosed
Send feedback